ArticleOncoimmunology
Vaccination targeting human HER3 alters the phenotype of infiltrating T cells and responses to immune checkpoint inhibition.
Takuya Osada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
trialcites it